Ann: Positive AD-214 Phase I extension study results, page-175

I wonder whether we get a smaller deal done whilst the bigger deal gets sorted? The top 20 pharma stumping up $45m + would be nice but Tim indicated that this wasn't the only pathway. I guess we can do is speculate and hope a deal gets done sooner rather than later. Sure for the options exercise but also the sooner the cash comes in the sooner we can start manufacturing the drug which takes around 9 months. So what I am wondering is do we get enough cash in to give the SP a splurge so otions get exercised whilst TO holds out for the best or right deal as indicated in his presentations. Personally I would like the big deal up front as no doubt we all would but better to wait for more maybe?